We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug News
Trending
Commercial Operations
GMPs
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Drug Weekly
FDAnews
Device News
Trending
Commercial Operations
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Device Weekly
FDAnews
Books
FDAnews Books Library
Drug Books
Device Books
Training/Events
Webinar Training Pass
Events
Webinar Recordings
Resources
Form 483s Database
FDA Approved Drugs
CenterWatch
About Us
The Company
FDAnews Editorial Board
Contact Us
Sign In
Create Account
Sign Out
My Account
Home
»
Store
» Generic Line
Search the Store
Shop By Category
Drug Products
Drug Books
Device Products
Device Books
Clinical Products
Shop By Media
Books
Webinar Recordings
Generic Line
-- Sort By --
New Arrivals
Best Sellers
Price: Low to High
Price: High to Low
A to Z
European Biosimilars Makers Weigh in on Latest Draft Guidelines
Price:
$40.00
Learn More
GPhA Unveils Compromise Language for Biosimilar Substitution Laws
Price:
$40.00
Learn More
ANDA Backlog, OPQ, Abuse-Deterrent Opioids Among Top CDER Priorities
Price:
$40.00
Learn More
PTO Board Upholds First Brand Patent in Generics Challenge
Price:
$40.00
Learn More
FDA Inspection Gave Beleaguered GVK Bio Plant Clean Bill of Health
Price:
$40.00
Learn More
Sandoz’s Preemptive Biosimilar Bid Against Amgen’s Enbrel Dismissed
Price:
$40.00
Learn More
FDA Accepts Apotex’s Pegfilgrastim Application as Biosimilars Movement Slowly Gains Steam
Price:
$40.00
Learn More
FDA’s Office of Pharmaceutical Quality Revs Up Process to Accelerate ANDA Reviews
Price:
$40.00
Learn More
Roxane Fails to Block Hetero’s Generic PhosLo
Price:
$40.00
Learn More
Opana Generic Delay Deal Target of Another Class Action Lawsuit
Price:
$40.00
Learn More
Sun Conducts Massive Recall Due to Poor Quality of APIs
Price:
$40.00
Learn More
FDA Considers Changes to 180-Day Exclusivity Decisions
Price:
$40.00
Learn More
Previous
1
2
…
14
15
16
17
18
19
20
21
22
Next